Pediatr Clin N Am 53 (2006) 257 277

Seizures in Children
Marla J. Friedman, DOa,T, Ghazala Q. Sharieff, MDb
a
Division of Emergency Medicine, Miami Childrens Hospital, 3100 SW 62nd Avenue,
Miami, FL 33155, USA
b
Childrens Hospital and Health Center, University of California, San Diego, 3030 Childrens Way,
San Diego, CA 92123, USA

Seizures are the most common pediatric neurologic disorder, with 4% to 10%
of children suffering at least one seizure in the first 16 years of life [1]. The
incidence is highest in children younger than 3 years of age, with a decreasing
frequency in older children [2]. Epidemiologic studies reveal that approximately
150,000 children will sustain a first-time, unprovoked seizure each year, and of
those, 30,000 will develop epilepsy [1].
A seizure is defined as a transient, involuntary alteration of consciousness,
behavior, motor activity, sensation, or autonomic function caused by an exces-
sive rate and hypersynchrony of discharges from a group of cerebral neurons. A
postictal period of decreased responsiveness usually follows most seizures, in
which the duration of the postictal period is proportional to the duration of seizure
activity. Epilepsy describes a condition of susceptibility to recurrent seizures. The
classic definition of status epilepticus refers to continuous or recurrent seizure
activity lasting longer than 30 minutes without recovery of consciousness.
During a seizure, cerebral blood flow, oxygen and glucose consumption, and
carbon dioxide and lactic acid production all increase. Early systemic changes
include tachycardia, hypertension, hyperglycemia, and hypoxemia. Brief seizures
rarely produce lasting effects on the brain. Prolonged seizures, however, can lead
to lactic acidosis, rhabdomyolosis, hyperkalemia, hyperthermia, and hypoglyce-
mia, all of which may be associated with permanent neurologic damage. Airway
management and termination of the seizure are the initial priorities in patients
who are actively seizing.

T Corresponding author.
E-mail address: [email protected] (M.J. Friedman).

0031-3955/06/$ see front matter D 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.pcl.2005.09.010 pediatric.theclinics.com
258 friedman & sharieff

Classification of seizures

Seizures are classified as generalized or partial. Generalized seizures are as-

sociated with the involvement of both cerebral hemispheres. They may be con-
vulsive, with prominent motor activity, or nonconvulsive. Motor involvement,
when present, is usually bilateral. Generalized seizures may also involve an al-
tered level of consciousness. Types of generalized seizures include tonic-clonic
(grand mal), tonic, clonic, myoclonic, atonic-akinetic (drop attacks) or absence
(petit mal) [3,4]. Generalized tonic-clonic seizures are the most common type of
childhood seizure. Most tonic-clonic seizures have a sudden onset, although a
small percentage of children may experience a motor or sensory aura. During
the initial tonic phase, the child becomes pale, with dilation of the pupils, de-
viation of the eyes, and sustained contraction of muscles with progressive ri-
gidity. Bladder or bowel incontinence is common. Clonic movements, involving
rhythmic jerking and flexor spasms of the extremities, then occur. Mental status is
usually impaired during the seizure and for a variable time after the seizure has
ceased. Myoclonic seizures are characterized by an abrupt head drop with arm
flexion and may occur up to several hundred times daily. Atonic seizures are
characterized by a sudden loss of both muscle tone and consciousness. Simple
(typical) absence seizures are uncommon before the age of 5 years and are
characterized by a sudden cessation of motor activity, a brief loss of awareness,
and an accompanying blank stare. Flickering of the eyelids may be seen. The
episodes last less than 30 seconds and are not associated with a postictal period.
Complex (atypical) absence seizures are usually associated with myoclonic
activity in the face or extremities and an altered level of consciousness [2,3].
Partial seizures may be simple, with no impairment of consciousness, or com-
plex, with altered mental status. Both simple and complex partial seizures may
progress to secondarily generalized seizures in up to 30% of children. Simple
partial seizures are associated usually with abnormal motor activity developing in
a fixed pattern on the hands or face. Although simple partial seizures are associ-
ated most commonly with motor abnormalities, sensory, autonomic, and psychic
manifestations also may be seen. Complex partial seizures (temporal lobe sei-
zures) are characterized by changes in perception and sensation, with associated
alterations in consciousness [3]. Seizures tend to affect the eyes (a dazed look),
the mouth (lip smacking and drooling), and the abdomen (nausea and vomiting)
[1]. There are other specific seizure syndromes that also occur in children.
Lennox-Gastaut syndrome has an onset between 3 and 5 years of age and is
characterized by intractable mixed seizures with a combination of tonic, myo-
clonic, atonic, and absence seizures. Most of these children also have accom-
panying mental retardation and severe behavioral problems. The EEG shows
an irregular, slow, high-voltage spike pattern [2,3]. Although many drugs have
been used to treat this condition, management is still very difficult. Valproic acid
is the drug used most commonly; however, felbamate, topiramate, lamotrigine,
and zonisamide have also been used as adjunctive therapies [5,6]. The ketogenic
diet has also been used with some success in these children [7].
 seizures in children 259

Children between 3 and 13 years of age who suffer from benign rolandic
epilepsy experience nighttime seizures during sleep. This seizure disorder is
genetically inherited as an autosomal dominant trait. The initial phase of the
seizure involves clonic activity of the face, including grimacing and vocali-
zations, which often wake the child from sleep. An electroencephalogram (EEG)
is important in the evaluation of this condition because a characteristic peri-
sylvian spiking pattern can be seen. Unless these seizures are frequent, no therapy
is needed because patients usually will outgrow these episodes by early adult-
hood. Carbamazepine has been used with success in the treatment of frequent
rolandic seizures [13,6].
Juvenile myoclonic epilepsy of Janz is inherited as an autosomal dominant
trait that manifests in early adolescence (onset 1218 years of age). Patients
experience myoclonic jerks typically on awakening but may also have tonic-
clonic (80%) or absence (25%) seizures. Typical provoking factors include stress,
alcohol, hormonal changes, or lack of sleep. The EEG is helpful in the diagnosis
because a pattern of fast spike-and-wave discharges can be seen. Valproic acid is
the drug of choice, with lamotrigine, topiramate, felbamate, and zonisamide as
alternate options [13,6].
Children with infantile spasms (Wests syndrome) present typically between
4 and 18 months of age, with males affected more commonly than females. Up to
95% of affected children are mentally retarded, and there is a 20% mortality rate.
Patients experience sudden jerking contractions of the extremities, head, and
trunk. The jerking is spasmodic and often occurs in clusters. Episodes rarely
occur during sleep. Up to 25% of patients have tuberous sclerosis. The EEG shows
the classic pattern of hypsarrhythmia (random high-voltage slow waves with
multifocal spikes) [2,3]. Treatment with adrenocorticotropic hormone (ACTH)
and prednisone has been used with some success [6,8]. Valproic acid, topiramate,
lamotrigine, vigabatrin, and zonisamide have also shown some effectiveness
[5,6,9,10].

Differential diagnosis

A seizure represents a clinical symptom of an underlying pathologic process

with many possible causes (Box 1). When a child presents with a seizure, every
effort should be made to determine the cause. It is imperative to differentiate
between a seizure and other nonepileptic conditions that may mimic seizure
activity (Box 2). A detailed description of the event from a witness is the most
important factor in an accurate diagnosis. If a historical detail does not seem
typical for a seizure, an alternative diagnosis should be considered.
Nonepileptic events that involve altered levels of consciousness are common
in childhood. Unlike seizures, there is no postictal phase following these epi-
sodes. Breath-holding spells affect approximately 5% of children between the
ages of 6 months and 5 years. A cyanotic spell begins with a period of vigor-
ous crying followed by breath-holding, cyanosis, rigidity, limpness, and often,
260 friedman & sharieff

Box 1. Causes of seizures

Infectious
Brain abscess
Encephalitis
Febrile seizure
Meningitis
Neurocysticercosis
Neurologic or developmental
Birth injury
Congenital anomalies
Degenerative cerebral disease
Hypoxic-ischemic encephalopathy
Neurocutaneous syndromes
Ventriculoperitoneal shunt malfunction
Metabolic
Hypercarbia
Hypocalcemia
Hypoglycemia
Hypomagnesemia
Hypoxia
Inborn errors of metabolism
Pyridoxine deficiency
Traumatic or vascular
Cerebral contusion
Cerebrovascular accident
Child abuse
Head trauma
Intracranial hemorrhage
Toxicologic
Alcohol, amphetamines, antihistamines, anticholinergics
Cocaine, carbon monoxide
Isoniazid
Lead, lithium, lindane
Oral hypoglycemics, organophosphates
Phencyclidine, phenothiazines
Salicylates, sympathomimetics
Tricyclic antidepressants, theophylline, topical anesthetics
Withdrawals (alcohol, anticonvulsants)
Idiopathic or epilepsy
Obstetric (eclampsia)
Oncologic
 seizures in children 261

Box 2. Pediatric conditions often mistaken for seizures

Disorders with altered consciousness

Apnea and syncope
Breath-holding spells
Cardiac dysrhythmias
Migraine
Paroxysmal movement disorders
Acute dystonia
Benign myoclonus
Pseudoseizures
Shuddering attacks
Spasmus mutans
Tics
Sleep disorders
Narcolepsy
Night terrors
Sleepwalking
Psychologic disorders
Attention deficit hyperactivity disorder
Hyperventilation
Hysteria
Panic attacks
Gastroesophageal reflux (Sandifers syndrome)

twitching of the extremities. A pallid spell begins with an inciting painful

stimulus, followed by pallor and a brief loss of consciousness. In both types of
breath-holding spells, recovery to baseline is rapid and complete. Syncope is a
brief, sudden loss of consciousness usually preceded by a feeling of light-
headedness. On recovery, the child may be pale and diaphoretic but responsive.
Patients with atypical migraines experience altered consciousness that is often
associated with blurred vision, dizziness, and a loss of postural tone [2,3,11].
Paroxysmal movement disorders involve abnormal motor activity and may
mimic seizures; however, altered consciousness is rare with these events. Tics are
brief, repetitive movements that may be induced by stress and are usually
suppressible. Shuddering attacks are whole-body tremors lasting a few seconds
with a rapid return to normal activity. Acute dystonia is characterized by an
involuntary sustained contraction of the neck and trunk muscles, with abnormal
posture and facial grimacing. Dystonic reactions in children are seen most often
as a side effect of certain medications. Pseudoseizures may present with a vari-
ety of paroxysmal movements, may be difficult to distinguish from a true sei-
zure, and are often seen in children who have a relative with epilepsy or in
patients who have a true seizure disorder. Features suggestive of a pseudoseizure
262 friedman & sharieff

include a lack of coordination of movements, moaning or talking during the

episode, the absence of incontinence or bodily injury, and suggestibility. Benign
myoclonus is marked by self-limited, sudden jerking movements of the ex-
tremities, usually on falling asleep. Spasmus nutans occurs in children 4 to
12 months of age and causes head tilt, nodding, and nystagmus. Infants with
Sandifers syndrome (gastroesophageal reflux) present with crying, vomiting,
and writhing, arching movements of the neck and back [2,3,11,12].
Some nonepileptic paroxysmal events are associated with sleep and can be
differentiated from seizures by their characteristic alterations in behavior. Night
terrors occur in the preschool-aged child, with a sudden awakening from sleep,
followed by crying, screaming, and inconsolability. The child then returns to
sleep and has no recollection of the event. Sleepwalking (somnambulism) is seen
in school-aged children who awaken from sleep with a glassy stare and walk
around aimlessly for several seconds. The child then falls back asleep easily on
returning to bed. Narcolepsy often presents in adolescence with an abrupt change
of alertness and uncontrollable daytime sleepiness. Oftentimes, narcolepsy is
associated with cataplexy, the sudden loss of muscle tone with preservation of
consciousness [2,3,11].

History and physical examination

Obtaining a detailed history is critical in the evaluation of a seizure because of

the many possible causes of a seizure as well as the numerous conditions that can
simulate a seizure. The history should focus on both the events immediately
before the onset of the episode as well as a thorough description of the actual
seizure. The information to elicit includes the duration, movements, eye findings,
cyanosis, loss of consciousness, the presence of an aura, incontinence, length of
the postictal period, and any post-seizure focal neurologic abnormalities. Further
information to obtain includes potential precipitating factors such as trauma,
ingestion, recent immunizations, fever, or other systemic signs of illness. Home
therapies for any recent illnesses should also be determined. If it is known that the
child has a seizure disorder, then it is important to ascertain whether the recent
seizure was different from previous seizures, the typical seizure frequency for the
patient, any medications the patient is taking, and whether the patient has been
compliant with the medication regimen or there have been any recent medication
changes. Additional history to elicit includes other significant medical problems
(neurologic disease, presence of a ventriculoperitoneal [VP] shunt, or devel-
opmental delay), recent travel history, and a family history of seizures.
A thorough physical and neurologic examination should be performed. Vital
signs, including temperature, heart rate, and blood pressure, should be obtained.
Fever is the most common cause of seizures in children (as discussed later). The
head should be examined for microcephaly, dysmorphic features, signs of trauma,
and the presence of a VP shunt. In infants, a measurement of the head circum-
ference may be helpful. A bulging fontanelle indicates increased intracranial
 seizures in children 263

pressure. The eyes should be examined for papilledema and retinal hemorrhages.
Evaluate the neck for signs of meningeal irritation. The presence of hepatospleno-
megaly may indicate a metabolic or glycogen storage disease. Assess the skin for
lesions such as cafe au lait spots (neurofibromatosis), adenoma sebaceum or ash
leaf spots (tuberous sclerosis), and port wine stains (Sturge-Weber syndrome).
Unexplained bruising should raise the suspicion of a bleeding disorder or child
abuse [3].

Diagnostic approach

Laboratory testing

Laboratory testing for a child who has an afebrile seizure should be guided by
the history and physical examination. A rapid bedside glucose test should be
performed. A drug level should be obtained in patients who are taking anti-
convulsant medications [4]. The determination of serum electrolytes, calcium,
magnesium, ammonia, white blood cell count, and toxicology screens may not be
necessary in a child who is alert and has returned to a baseline level of function
and should be based on clinical suspicion [13]. In patients who have no iden-
tifiable risk factors, an accurate and thorough history and physical examination
have been shown to yield more diagnostic information than a laboratory evalua-
tion [14]. However, newborns and infants less than 6 months of age have been
found to be at a greater risk for electrolyte abnormalities because of underlying
metabolic abnormalities, specifically hyponatremia resulting from the increased
free water intake from formula overdilution [15]. Patients who have abnormal
electrolyte values are more likely to have been actively seizing on presentation,
have hypothermia (temperature less than 36.58C), or be younger than 1 month of
age [16]. A temperature lower than 36.58C has been shown to be the best
predictor of hyponatremia-induced seizures in infants younger than 6 months of
age [17]. Based on the results of these reports, it is reasonable to obtain laboratory
studies on pediatric patients who have prolonged seizures, are younger than
6 months of age, have a history of diabetes, metabolic disorder, dehydration, or
excess free water intake, and patients who have an altered level of consciousness.
Routine lumbar puncture is not indicated in patients who are alert and oriented
after a first afebrile seizure. A lumbar puncture should be considered after
neonatal seizures occur and should be performed in patients who have an altered
mental status, signs of meningeal irritation, or a prolonged postictal period [13].

Neuroimaging

Emergent neuroimaging typically is not necessary in well-appearing children

after a first, unprovoked nonfebrile seizure [13]. Radiologic imaging of the
seizure patient in an emergency setting usually consists of a computed CT scan
of the brain. A CT scan is indicated in the acute evaluation of patients who have
264 friedman & sharieff

a focal seizure or persistent seizure activity, a focal neurologic deficit, a VP shunt,

a neurocutaneous disorder, signs of elevated intracranial pressure, and a history of
trauma or travel to an area endemic for cysticercosis. Patients who have immuno-
compromising diseases (malignancy or HIV), hypercoagulable states (sickle cell
disease), or bleeding disorders are also candidates for emergent imaging [18,19].
A MRI study is more sensitive than a cranial CT scan for the detection of certain
tumors and vascular malformations. However, MRI is not readily available on an
emergent basis [3,4]. Emergent imaging should be performed only in patients
who have high-risk criteria. Low-risk patients can be discharged for follow-up
without undergoing immediate imaging [13].

Electroencephalography

An EEG is rarely needed in the acute setting, except for patients who have
refractory seizures or in patients in whom the diagnosis of nonconvulsive status
epilepticus is being considered. Well-appearing children who have experienced a
first-time afebrile seizure should be referred for outpatient EEG testing [3,4]. An
ictal EEG taken during a seizure event is most useful, but because this is not
always possible, a complete EEG recording should include both sleep and wake
cycles as well as periods of patient stimulation. It is important to note, however,
that a normal EEG does not rule out epilepsy or other underlying neurologic
disorders [20].

Management

Acute stabilization

Status epilepticus should be considered in any patient who presents to an acute

care setting with active seizure activity. An algorithm for the management of
status epilepticus is presented in Fig. 1. The initial management should focus on
the stabilization of the airway, breathing, and circulation and stopping the seizure.
The patient should be positioned to allow for an open airway, and if necessary, an
oral or nasal airway should be inserted. Oxygen should be administered and
further equipment for assisted ventilation should be at the bedside. Intravenous
(IV) access should be established promptly. The actively convulsing patient
should also be protected from self-inflicted trauma. A rapid glucose level de-
termination should be performed at the bedside, and a glucose infusion should be
initiated for documented hypoglycemia. Dextrose should not be given empirically
to children on ketogenic diets because this will break the ketogenic state and may
result in increased seizure activity. Naloxone should be administered in cases of
suspected drug exposures. The dministration of pyridoxine should be considered
in neonates and those with possible isoniazid ingestion [2124].
Most patients who present with active convulsions will require pharmacologic
treatment to end the seizure. Benzodiazepines are the initial drugs of choice for
 seizures in children 265

Establish ABCs: Maintain airway, give oxygen, support ventilation, establish IV access

Consider IV glucose, naloxone, or pyridoxine based on clinical scenario

First dose of benzodiazepine: Lorazepam 0.05 0.1 mg/kg IV

Diazepam 0.5 mg/kg PR
Midazolam 0.2 mg/kg IM

Seizure continues at 5-15 min May repeat benzodiazepine 1-2x

Phenytoin or fosphenytoin 15-20 mg/kg IV

Seizure continues at 15-30 min

Phenobarbital 20 mg/kg IV

Seizure continues > 30 min Re-assess airway/consider intubation

Continuous infusion of pentobarbital, midazolam, propofol

Seizure continues > 60 min Intubate now

General anesthesia

Fig. 1. An algorithm for the management of status epilepticus. ABC, airway, breathing, circulation;
PR, administered rectally.

the acute management of seizures [21,24]. Lorazepam is the preferred agent

because of its rapid onset (25 minutes) and long half-life (1224 hours). It can
be given in the IV or intramuscular (IM) form at a dose of 0.05 to 0.1 mg/kg
(maximum 4 mg/dose). The dose may be repeated after 5 to 15 minutes, but the
drugs effectiveness decreases with subsequent doses [4,24]. Diazepam has a
rapid onset but a much shorter half-life (less than 30 minutes) than lorazepam.
If diazepam is given for seizure termination, a long-term agent should be used
in addition to prevent seizure recurrence. Diazepam can be given in a dose of
0.2 to 0.4 mg/kg IV or intraosseous (IO) (maximum 10 mg/dose). If IV access is
not readily available, diazepam can also be given rectally, administering the
IV formulation at a dose of 0.5 mg/kg [2426]. Another agent to consider is
midazolam, which can be administered by many routes, including IV, IM, rectal,
intranasal, and buccal [24,2628]. The major side effects of the benzodiazepines
are respiratory depression and sedation, especially with repeated doses or in
combination with a barbiturate.
Phenytoin or fosphenytoin is administered if a seizure continues despite the
use of benzodiazepine. Phenytoin can only be instilled by IV at a loading dose of
10 to 20 mg/kg, with each 1 mg/kg of drug given, raising the serum concentration
266 friedman & sharieff

by 1 mg/mL. Phenytoin has a peak effect at 10 to 20 minutes after completion of

the infusion and a duration of action of 12 to 24 hours. Phenytoin must be
administered slowly (0.51.0 mg/kg/min to a maximum of 50 mg/kg/min) and
under cardiac monitoring because of the risk of hypotension and cardiac dys-
rhythmias with rapid infusion. Furthermore, it cannot be mixed in a dextrose-

Table 1
Common anticonvulsant agents
Maintenance
Drug Indication Side effects (mg/kg/d)
Carbamazepine Generalized tonic-clonic, partial, Rash, hepatitis, diplopia, 10-40 mg/kg/day
(Tegretol) benign rolandic seizures aplastic anemia, leukopenia
Clonazepam Myoclonic, akinetic, partial Fatigue, behavioral issues, 0.050.30
(Klonopin) seizures, infantile spasms, salivation
Lennox-Gastaut
Ethosuximide Absence GI upset, weight gain, 2040
(Zarontin) lethargy, SLE, rash
Felbamate Refractory severe epilepsy Aplastic anemia, 1545
(Felbatol) hepatotoxicity
Gabapentin Partial and secondarily Fatigue, dizziness diarrhea, 2070
(Neurontin) generalized seizures ataxia
Lamotrigine Complex partial, atonic, myo- Headache, nausea, rash, 515
(Lamictal) clonic, absence, tonic-clonic, diplopia, Stevens-Johnson
Lennox-Gastaut, infantile spasms synd, GI upset
Levetiracetam Adjunctive therapy for Headache,anorexia, fatigue, 1060
(Keppra) refractory partial seizures infection
Oxcarbazepine Adjunctive therapy for partial Fatigue, low sodium, 1045
(Trileptal) seizures nausea, ataxia, rash
Phenobarbital Generalized tonic-clonic, partial, Sedation, behavioral issues 26
(Luminol) myoclonic
Phenytoin Generalized tonic-clonic, partial, Gum hyperplasia, hirsutism, 48
(Dilantin) atonic, myoclonic, neonatal ataxia, Stevens-Johnson
syndrome, lymphoma
Primidone Generalized tonic-clonic, partial Rash, ataxia, behavioral 1025
(Mysoline) issues, sedation, anemia
Tiagabine Adjunctive therapy for Fatigue, headache tremor, Titrate from
(Gabitril) refractory complex partial dizziness, anorexia 0.10 mg/kg/d;
(focal) seizures avg. dose
6 mg/d
Topiramate Refractory complex partial Fatigue, nephrolithiasis, 19
(Topamax) seizures, adjunctive therapy ataxia, headache, tremor,
for temporal lobe epilepsy GI upset
Valproic acid Generalized tonic-clonic, GI upset, liver involvement, 1060
(Depakote) absence, myoclonic, partial, tremor, alopecia, sedation,
akinetic, infantile spasms weight gain
Vigabatrin Infantile spasms, adjunctive Weight gain, behavior 30150
(Sabril) therapy for refractory seizures changes, visual field
constriction
Zonisamide Adjunctive therapy for partial Fatigue, ataxia, anorexia, 28
(Zonegran) seizures, atonic, infantile spasms GI upset, headache, rash
Abbreviation: SLE, systemic lupus erythematosus.
 seizures in children 267

containing solution because of precipitation problems. Local reactions such as

thrombophlebitis are common following infusion, and tissue necrosis may be
seen with accidental infiltration [4,2124]. Fosphenytoin is a prodrug developed
recently whose active metabolite is phenytoin. Its advantages include a more
rapid administration (3 mg/kg/min to a maximum of 150 mg/min), fewer local
and systemic side effects, the option of IM injection, and the ability to give the
drug in a saline or dextrose-containing solution. The drug is dosed as phenytoin
equivalents (PE) with a loading dose of 10 to 20 mg of PE/kg [4,24,29].
Phenobarbital is the next drug to be added if seizures persist. In neonates,
however, phenobarbital is the initial drug of choice. It is given in a loading dose
of 20 mg/kg, with an onset of action in 15 to 20 minutes and an anticonvulsant
duration effect of between 24 and 120 hours. It causes significant sedation,
hypotension, and respiratory depression, especially when used in conjunction
with a benzodiazepine [4,2124].
Continuous infusions of pentobarbital, midazolam, or propofol may be needed
for refractory seizures. The patient should be ventilated mechanically and have
continuous EEG monitoring. The medication should be titrated to maintain a flat-
line or suppression pattern on the EEG. If seizures continue for more than 1 hour
despite the above therapies, patients may require general anesthesia, neuro-
muscular blockade, and continuous EEG monitoring in an intensive care setting
[3,2123].

Long-term treatment

The decision to initiate treatment with an anticonvulsant medication is based

on many factors. Considerations include the patients age, type of seizure, risk of
recurrence, and other predisposing medical issues. Maintenance medications are
usually not initiated for stable, well-appearing children after a single afebrile
seizure. Although anticonvulsant agents may decrease the incidence of a second
seizure, they do not reduce the long-term risk of developing epilepsy. Patients
who experience recurrent seizures, however, should be started on an antiepileptic
medication. The decision to initiate long-term anticonvulsant therapy should be
made in conjunction with the patients primary care provider or a neurologist
[13,20,30].
There are numerous agents available to prevent pediatric seizures (Table 1).
Several guidelines have been suggested to aid in the choice of an anticonvulsant
medication [3,10,31].

1. Choose an agent that is effective for the particular type of seizure. If several
drugs are available, use the drug that is least toxic.
2. Initiate therapy with a single agent.
3. Start at the low end of the dosage range.
4. Continue the same drug for at least long enough to reach a steady state,
usually five times the half-life of the drug.
268 friedman & sharieff

5. Increase the dosage until seizure control is achieved or unacceptable side

effects occur.
6. Consider adding another agent if the patient continues to have sei-
zure activity. Aim for a goal of monotherapy by eventually eliminating the
first drug.

Carbamazepine (Tegretol) is useful for treating generalized tonic-clonic, sim-

ple, and complex partial seizures. It is also the drug of choice for treating be-
nign rolandic epilepsy [2]. Recommended maintenance doses range from 10 to
40 mg/kg divided into 2 or 3 daily doses. Doses should be started at 5 mg/kg/d
and increased by 5 mg/kg every 3 to 4 days until an effective maintenance level
is achieved. Therapeutic serum levels range from 4 to 12 mg/mL. Dose-related
adverse effects include drowsiness, blurred vision, and lethargy. Other side ef-
fects include rash, leukopenia, aplastic anemia, and hepatic toxicity. Toxic car-
bamazepine levels may result from the concomitant use of macrolide antibiotics,
cimetidine, isoniazid, and certain calcium channel blockers. Carbamazepine may
also interfere with the effectiveness of oral contraceptives [3032].
Phenytoin (Dilantin) is effective against generalized tonic-clonic and both
types of partial seizures. The usual maintenance dose ranges from 4 to 8 mg/kg/d
given once, twice, or three times daily. Therapeutic serum levels range from 10 to
20 mg/mL. Because of varying rates of absorption of the drug, small dosage
changes can result in large changes in serum drug levels. Similarly, drug levels
may also be affected if either the trade or generic form of the drug is substituted
for the other. Nondose-dependent adverse effects include gingival hyperplasia,
hirsutism, and acne. These cosmetic side effects may limit the drugs long-term
use, especially in girls. Other side effects include drug-induced rashes (Stevens-
Johnson syndrome) and blood and liver toxicity. Dose-related toxic effects, such
as nausea, vomiting, drowsiness, ataxia, and nystagmus, usually occur with levels
outside the therapeutic range. Phenytoin can interfere with the effectiveness of
other anticonvulsant agents, decreasing serum levels of carbamazepine, clonaze-
pam, and primidone, and increasing the serum concentration of phenobarbital.
The administration of cimetidine, estrogens, chlorpromazine, chloramphenicol,
isoniazid, and anticoagulants may result in an increased phenytoin drug level
[24,3032].
Phenobarbital (Luminol) is useful for treating generalized tonic-clonic and
partial seizures and is a first-line agent for treating neonatal seizures. The usual
dose ranges from 2 to 6 mg/kg/d, given once or twice daily, with a therapeutic
range of 10 to 40 mg/mL. Phenobarbital is fairly inexpensive and so is used
commonly as a the initial drug. However, it does have several undesirable side
effects in 30 to 50% of children who experience hyperactivity, mood alterations,
cognitive dysfunction, and sleep problems. These common behavioral effects
cause many clinicians to limit the use of this drug [24,30,32].
Primidone (Mysoline) is metabolized to phenobarbital, so the two drugs are
useful for treating the same types of seizures, and both cause similar side effects.
The usual dose is between 10 and 25 mg/kg/d, given in two to four divided doses.
 seizures in children 269

Maintenance doses should be started at the low end of the dosage range because
excessive sedation and ataxia are common at higher doses. The therapeutic range
is between 5 and 12 mg/mL and is measured by monitoring the serum level of
phenobarbital [3032].
Valproate (Depakote) is quite effective for the treatment of absence and myo-
clonic seizures but can be used for generalized tonic-clonic and partial seizures as
well. Valproic acid has also been used with success in the treatment of Lennox-
Gastaut seizures, juvenile myoclonic epilepsy of Janz, and occasionally in the
management of infantile spasms [2,5]. The typical maintenance dose ranges from
10 to 60 mg/kg/d, divided two to four times daily. Daily doses should be initiated
at 10 mg/kg and increased by 10 mg/kg weekly until a therapeutic serum level of
50 to 100 mg/mL is established. Common side effects include gastrointestinal (GI)
upset, weight gain, drowsiness, and alopecia. Tremors and thrombocytopenia are
dose-related effects. Children less than 2 years of age are at an increased risk for
liver and pancreatic toxicity. Valproate interferes with the metabolism of other
anticonvulsant agents and may increase the drug levels of phenobarbital, phe-
nytoin, carbamazepine, diazepam, clonazepam, and ethosuxamide [3032].
Ethosuxamide (Zarontin) is most effective for the treatment of absence sei-
zures. The maintenance dose ranges from 20 to 40 mg/kg/d, divided into two
daily doses, with an optimal therapeutic serum level of 40 to 100 mg/mL. Com-
mon side effects include GI upset, weight gain, and headache, with the rare
occurrence of erythema multiforme and a lupus-like syndrome [30,31].
Clonazepam (Klonopin) is useful for the management of myoclonic and atonic
seizures. The usual dose is 0.05 to 0.3 mg/kg/d, given in two to four divided
doses, with a therapeutic range of 0.02 to 0.08 mg/mL. Side effects include
drowsiness, ataxia, and drooling [31,32].
Lamotrigine (Lamictal) is indicated for the management of partial, atonic,
myoclonic, and tonic seizures, as well as Lennox-Gastaut syndrome. The main-
tenance dose ranges from 5 to 15 mg/kg/d, but because the drug interferes with
other anticonvulsant agents, the dosage should be adjusted when used in con-
junction with other antiepileptic medications. Lamictal should be initiated at
low doses in patients who are also taking valproic acid and at higher doses when
used in conjunction with phenytoin, carbamazepine, phenobarbital, or primidone.
Lamictal is generally well tolerated, with most side effects being transient or
dose-related, including GI upset, somnolence, dizziness, headache, and diplopia.
The adverse effect of most concern is the development of a rash (Stevens-
Johnson syndrome), which is especially common in patients who are also taking
valproic acid [6,10,24,30,33].
Felbamate (Felbatol) is used mainly to treat intractable seizures that are
refractory to other treatments, mainly the seizures of Lennox-Gastaut syndrome.
The usual dose is 15 to 45 mg/kg, divided three to four times daily. It should be
started at the low end of the dosage range and should be used as monotherapy
because the risk of adverse effects is increased when it is used with other agents.
Felbamae is known to increase the serum concentrations of phenobarbital, phe-
nytoin, and valproic acid and to decrease that of carbamazepine. Side effects
270 friedman & sharieff

include anorexia, nausea, vomiting, insomnia, and lethargy, with the major
adverse effects of aplastic anemia and severe hepatotoxicity being reported as
well. Children taking this medication should have blood counts and liver en-
zymes monitored frequently [6,10,30,33].
Gabapentin (Neurontin) is indicated for the management of partial and sec-
ondarily tonic-clonic seizures at a dose of 20 to 70 mg/kg/d. The dose should
be given three to four times daily because of the drugs short half-life. A major
advantage of gabapentin is its lack of notable adverse effects. Minor side effects
may include fatigue, dizziness, ataxia, and diarrhea. Increased appetite and
weight gain may also occur [6,10,24,30,33].
Vigabatrin (Sabril) is effective for treating refractory partial seizures and
infantile spasms. The maintenance dose is between 30 and 150 mg/kg/d, given
once or twice daily. If seizures do not improve while on the drug, the patient is
considered to be resistant to the drug. In some infants who have infantile spasms,
treatment with vigabatrin resulted in the development of partial seizures, which is
considered by some experts to be an improvement. The most impressive response
has been seen in infants with tuberous sclerosis, with an efficacy similar to ACTH
[10]. Side effects include weight gain, hyperactivity, and behavioral changes. The
development of visual field constriction is a serious side effect that has limited the
use of this drug [6,10,24,30].
Topiramate (Topamax) is indicated as adjunctive therapy in treating children
with partial or generalized tonic-clonic seizures. It has also been effective in the
treatment of Lennox-Gastaut syndrome, infantile spasms, and refractory complex
partial seizures. The initial dose starts at 1 mg/kg/d, with a target maintenance
dose of 3 to 9 mg/kg/d. The drugs interaction with other anticonvulsant agents is
minor. Topiramate produces several adverse effects of concern, with behavioral
problems being the most common in children. Other side effects include
anorexia, weight loss, sleep problems, fatigue, headache, diplopia, speech prob-
lems, and confusion. Nephrolithiasis is another serious effect of topiramate, and
its use should be carefully considered in patients who have a history of kidney
stones or those on a ketogenic diet [6,10,24,30,33].
Tiagabine (Gabitril) is indicated as adjunctive therapy for managing refractory
partial seizures. Dosing should begin at 0.1 mg/kg/d and be adjusted to a target
dose of 0.5 to 1 mg/kg/d until adequate seizure control is achieved. Adverse
effects are dose-related and more common with polytherapy. Reported side ef-
fects include fatigue, dizziness, headache, difficulty concentrating, and depressed
mood [6,10,24,30,33].
Levetiracetam (Keppra) is effective as adjunctive therapy for refractory partial
seizures in children aged 6 to 12 years of age. Usual maintenance doses range
from 10 to 60 mg/kg/d. Adverse effects in the pediatric population include head-
ache, anorexia, fatigue, and infection, including rhinitis, otitis media, gastro-
enteritis, and pharyngitis. Leukopenia has been reported in the adult literature
but no such effect has been demonstrated in children [6,33].
Oxcarbazepine (Trileptal) is indicated as adjunctive therapy for treating par-
tial seizures in children. Initial dosing begins at 5 mg/kg/d and is titrated upward,
 seizures in children 271

as needed, to 45 mg/kg/d. Serum concentrations of phenobarbital and phenytoin

may be increased when used in conjunction with oxcarbazepine. Adverse effects
include somnolence, nausea, ataxia, diplopia, and a hypersensitivity rash. Ap-
proximately 25% of children who have had an allergic reaction to carbamazepine
will develop a similar reaction to oxcarbazepine [6,33].
Zonisamide (Zonegran) is indicated as adjunctive therapy against partial
seizures in children 16 years of age and older. It is also effective against gen-
eralized tonic-clonic, myoclonic, and atonic seizures as well as treatment for
infantile spasms and Lennox-Gastaut syndrome. The initial dose is 2 to 4 mg/kg/d,
given two or three times daily, with a maintenance range of 4 to 8 mg/kg/d.
Common side effects include fatigue, GI upset, anorexia, ataxia, and rash. Ad-
verse effects are more common early in the course of therapy and are less prob-
lematic with gradual dosage adjustments [6,33].
The ketogenic diet should be considered in children with refractory tonic,
myoclonic, atonic, and atypical absence seizures whose seizures have failed to
respond to standard anticonvulsant therapy. This diet has also been effective in
the treatment of infantile spasms and Lennox-Gastaut syndrome. Studies have
demonstrated a 50% to 70% reduction in seizures in children on the ketogenic
diet [6,7]. The premise of therapy is that starvation will produce a ketosis that is
associated with seizure reduction. The therapy is initiated with a 5- to 7-day
inpatient hospital stay during which starvation is instituted until ketosis is
achieved. Hypoglycemia is common during this starvation phase, and blood
glucose levels must be aggressively monitored. Vomiting and dehydration may
also occur during this initiation phase. A diet of 3 to 4 parts fat to 1 part carbo-
hydrate and protein is then introduced. Vitamin and mineral deficiencies should
be avoided with appropriate supplementation. Metabolic abnormalities that
may develop include renal tubular acidosis, hypoproteinemia, and elevated lipids
and hepatic and pancreatic enzymes. Other effects include infection and pro-
longed QT intervals. Therefore, an EKG and metabolic evaluation (including
evaluation for inborn errors of metabolism) should be performed before initiating
the diet. Laboratory studies should be monitored routinely during therapy as well
[3,6,24].

Disposition

Well-appearing children may be managed following a first-time afebrile

seizure on an outpatient basis, with the appropriate follow-up. Seizure first aid
should be explained to the family before discharge. These children do not require
anticonvulsant therapy, but they should be scheduled for EEG testing [3]. The
overall recurrence rate in children with a first unprovoked afebrile seizure varies
from 14% to 65%, with most recurrences seen in the first 2 years after the initial
event [10,14]. The EEG has been found to be the most important predictor of
recurrence, with a 2-year recurrence rate of 58% in patients who have an ab-
272 friedman & sharieff

normal EEG result compared with a 28% seizure recurrence rate in patients who
have a normal EEG result [34].
The decision to initiate drug therapy and the choice of anticonvulsant agent
should be made in conjunction with the patients primary care provider and,
oftentimes, in consultation with a neurologist [14]. These choices are complicated
and should consider the risks associated with a seizure (recurrence, chance of
injury, and psychosocial implications) against those of drug therapy (toxicity,
effects on behavior and intelligence, and expense) [2,3]. Children with a pro-
longed seizure or postictal state or status epilepticus should be hospitalized for
further observation and evaluation.

Special considerations

Neonatal seizures

It is often difficult in the newborn to differentiate between a seizure from other

conditions, especially because newborns seizures can present in a variety of dif-
ferent ways, including apnea, subtle eye deviations, or abnormal chewing move-
ments. In addition, associated autonomic system findings seen commonly with
older seizure patients may not be apparent in neonates. A useful tip in differ-
entiating between a newborn who has a seizure and a jittery baby is that true
seizures cannot be suppressed by passive restraint, whereas seizures cannot be
elicited by motion or startling [35].
The most common cause of a seizure in the first 3 days of life is perinatal
hypoxia or anoxia. Approximately 50% to 65% of newborn seizures are caused
by hypoxic-ischemic encephalopathy [36]. Intraventricular, subdural, and sub-
arachnoid hemorrhages account for 15% of newborn seizures, and an additional
10% are caused by inborn errors of metabolism, sepsis, metabolic disorders, and
toxins [37,38]. Pyridoxine deficiency is an autosomal recessive disorder that is a
rare cause of newborn seizures and usually presents in the first 1 to 2 days of life
[39]. These seizures will not respond to the usual therapy for status epilepticus
but do respond readily to supplemental pyridoxine at a dose of 50 to 100 mg IV.
Benign familial neonatal convulsions and benign idiopathic neonatal con-
vulsions are two types of neonatal seizures that carry a favorable prognosis.
Benign familial neonatal convulsions typically present in the first 3 days of life in
infants with a strong family history of epilepsy or neonatal seizures. The cause is
unknown, but these seizures resolve by 1 to 6 months of age. Benign idiopathic
neonatal convulsions, also known as fifth day fits, present on the fifth day of
life and cease by day 15 of life [39].
The evaluation of neonatal seizures includes a thorough investigation for an
underlying cause. Cranial imaging may consist of an ultrasonogram, a head CT,
or MRI. Laboratory studies including electrolytes, glucose, calcium, magnesium,
toxicology screen, urinalysis and culture, complete blood count and blood cul-
ture, and cerebrospinal fluid (CSF) studies should also be obtained. If an inborn
 seizures in children 273

error of metabolism is suspected, then blood should be tested for amino acids,
lactate, and pyruvate and ammonia levels, and urine should be tested for or-
ganic acids.
The immediate management of active neonatal seizures includes attention to
the airway, breathing, and circulation and therapy to end the seizure. Benzo-
diazepines are often given as the first line of treatment but have been associated
with serious adverse effects such as hypotension and respiratory depression in
preterm and term infants, and therefore should be used with caution [3840]. A
long-acting anticonvulsant, usually phenobarbital, and then fosphenytoin are
added [36]. Phenytoin is not a preferred initial agent because it has a depressive
effect on the newborn myocardium and an unpredictable rate of metabolism in
neonates because of immature hepatic function [38,39]. Topiramate and zonis-
amide are new agents that have also shown effectiveness in the treatment of
neonatal seizures [35]. Pyridoxine or lidocaine may be used if refractory seizures
are present [39]. If the seizure is a result of an electrolyte abnormality such as
hyponatremia, hypocalcemia, or hypomagnesemia, then these abnormalities
should be identified and treated rapidly. Ampicillin and either cefotaxime or
gentamicin should be initiated in any patient who is suspected of having sepsis.
Acyclovir also should be administered if there is a positive maternal history of
herpes or the patient has a vesicular rash, focal neurologic findings, or a CSF
pleocytosis or elevated CSF protein without organisms on Gram stain. Patients
should be admitted to a monitored bed for further observation and evalua-
tion [35].

Febrile seizures

Febrile seizures are the most common type of seizure in young children, with a
2% to 5% incidence of children experiencing at least one seizure before the age
of 5 years [1,41]. A febrile seizure is defined as a convulsion that occurs in
association with a febrile illness in children between 6 months and 5 years of age.
A simple febrile seizure is single, brief (!15 minutes), and generalized. A com-
plex febrile seizure is much less common (approximately 20%) and is recurrent
in a single illness, prolonged ("15 minutes), and focal.
The peak age for febrile convulsions is between 18 and 24 months. The exact
pathophysiology is unknown, but it seems that a fever lowers the seizure thresh-
old in susceptible children. It is unclear if the seizures are related to the rate of
rise of the temperature or to the absolute peak sustained temperature [4143]. A
strong genetic predisposition exists, with a family history of febrile seizures
present in 25% to 40% of children with febrile seizures [24].
Most febrile seizures are benign and self-limited, with no long-term neurologic
or cognitive effects identified [4143]. Approximately one third of children who
experience a first febrile seizure will have at least one recurrence, and less than
10% of children will have more than three seizures. Most recurrences (75%)
occur within 1 year of the initial episode. The younger the child is at the time of
274 friedman & sharieff

the first seizure, the greater the likelihood of recurrence, with approximately 50%
of children younger than 1 year of age having a recurrence [42]. Children who
have higher temperatures at the time of the seizure have a lower likelihood of
recurrence. A complex first febrile seizure neither alters the risk of recurrence nor
predicts that recurrent seizures, if they occur, will be complex [1].
Febrile seizures occur in otherwise healthy children with no signs of men-
ingitis, encephalitis, or other neurologic disorders. In these cases of typical
febrile seizures, an extensive laboratory evaluation has been found to have low
yield and is unnecessary [41]. Viral infections have been implicated in most cases
in which a cause has been determined. Specifically, roseola infantum (human
herpesvirus 6) and influenza A have been associated with an increased incidence
of febrile seizures [44,45]. Children who have simple febrile seizures have the
same risk for serious bacterial infections as children with fever alone [43,46,47].
In children younger than 1 year of age, clinical signs of meningitis may be
subtle or lacking. Previous American Academy of Pediatrics guidelines recom-
mended that a lumbar puncture (LP) be strongly considered in all infants less than
12 months of age and considered in those between 12 to 18 months of age [41].
However, a recent article [43] now recommends LP in infants less than 18 months
of age only if the following are present: (1) a history of irritability, lethargy,
or poor oral intake; (2) an abnormal appearance or mental status changes; (3)
abnormal physical examination findings such as a bulging fontanelle, Brudzin-
skis sign, or severe headache; (4) any complex seizure features; (5) slow pos-
tictal clearance of mental status; and (6) pretreatment with antibiotics. Therefore,
performing routine LPs in children with simple febrile seizures may no longer be
necessary. EEG and cranial imaging are not routine aspects of the evaluation of a
simple febrile seizure. Further diagnostic tests (blood and urine studies) should be
ordered only to investigate the source of the fever based on the childs age and
extent of the fever [41,46].
The treatment of a patient who presents during a febrile seizure is the same as
for other seizure types. The initial priority should focus on stabilization of the
airway, breathing, and circulation, with efforts then directed at terminating the
seizure. The reduction of body temperature with antipyretics or other cooling
methods should also be a part of the primary management. If the seizure persists,
benzodiazepines are the first drug of choice. Phenytoin and phenobarbital may be
used as second-line agents for persistent seizure activity [42].
Most febrile seizures, however, are brief, and patients will usually present for
evaluation after the seizure activity has ceased spontaneously. For these patients,
the issue of prophylactic medication therapy is controversial. The current con-
sensus is that long-term medication therapy is not necessary for most patients
who have simple febrile seizures. Following a febrile seizure, children with no
other risk factors for epilepsy (a family history of epilepsy, a complex febrile
seizure, or an underlying neurologic disorder) have only a 1% to 2% lifetime risk
of developing epilepsy compared with a 0.5% to 1% risk in the general popu-
lation [42]. In the presence of two or more of these risk factors, the future risk of
developing epilepsy is 10%.
 seizures in children 275

Prophylactic antipyretic therapy is not effective in reducing the risk of sei-

zure recurrence. Anticonvulsant therapy may reduce recurrences but does not
prevent the development of epilepsy. Most children with febrile seizures do
not require anticonvulsant therapy. Phenobarbital has been used in the past for
the long-term management of febrile seizures. To be effective, phenobarbital
must be given continuously, not intermittently or at the onset of fever. Concerns
about adverse behavioral and cognitive effects have limited its use. Valproic acid
seems to be at least as effective as phenobarbital in preventing recurrent fe-
brile seizures, but its association with severe hepatotoxicity in children less than
3 years of age has limited its use. Other agents, such as carbamazepine and
phenytoin, are not effective in the prevention of recurrences. Oral or rectal
diazepam, 0.5 mg/kg/d, given intermittently from the onset of fever has been
shown to be as effective as continuous phenobarbital in preventing seizures [42].
Again, adverse effects (ataxia, lethargy, and irritability) may restrict the use of
this therapy. Long-term prophylactic therapy may be considered in certain in-
dividualized cases.
Patients with a simple febrile seizure may be safely discharged to home with
parental reassurance and seizure education. Those patients who have had a
complex or prolonged seizure or required medication to terminate the seizure
should be hospitalized.

References

[1] McAbee GN, Wark JE. A practical approach to uncomplicated seizures in children. Am Fam
Physician 2000;62(5):1109 16.
[2] Vining EP. Pediatric seizures. Emerg Med Clin North Am 1994;12(4):973 88.
[3] Shneker BF, Fountain NB. Epilepsy. Dis Mon 2003;49:426 78.
[4] Reuter D, Brownstein D. Common emergent pediatric neurologic problems. Emerg Med Clin
North Am 2002;20(1):155 76.
[5] Trevathan E. Infantile spasms and Lennox-Gastaut syndrome. J Child Neurol 2002;17(Suppl 2):
2S9 22.
[6] Jarrar RG, Buchhalter JR. Therapeutics in pediatric epilepsy, part 1: the new antiepileptic drugs
and the ketogenic diet. Mayo Clin Proc 2003;78:359 70.
[7] Vining EP, Freeman JM, Ballaban-Gil K, et al. A multi-center study of the efficacy of the
ketogenic diet. Arch Neurol 1998;55(11):1433 7.
[8] Cossette P, Riviello J, Carmant L. ACTH versus vigabatrin therapy in infantile spasms: a retro-
spective study. Neurology 1999;52(8):1691 4.
[9] Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with
infantile spasms. Neurology 2001;57(8):1416 21.
[10] Marks WJ, Garcia PA. Management of seizures and epilepsy. Am Fam Physician 1998;57(7):
1589 600.
[11] Barron T. The child with spells. Pediatr Clin North Am 1991;38(3):711 24.
[12] Selbst SM, Clancy R. Pseudoseizures in the pediatric emergency department. Pediatr Emerg
Care 1996;12(3):185 8.
[13] Hirtz D, Ashwal S, Berg A, Bettis D, et al. Practice parameter: evaluating a first nonfebrile
seizure in children. Neurology 2000;55:616 23.
[14] Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first unprovoked
seizure. Neurology 2003;60:166 75.
276 friedman & sharieff

[15] Bui T, Delgado C, Simon H. Infant seizures not so infantile: first-time seizures in children under
six months of age presenting to the ED. Am J Emerg Med 2002;20:518 20.
[16] Scarfone RJ, Pond K, Thompson K, et al. Utility of laboratory testing for infants with seizures.
Pediatr Emerg Care 2000;16:309 12.
[17] Farrar HC, Chande VT, Fitzpatrick DF, et al. Hyponatremia as the cause of seizures in infants:
a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med 1995;
26:42 8.
[18] Warden C, Browenstein D, Del Beccaro M. Predictors of abnormal findings of computed
tomography of the head in pediatric patients presenting with seizures. Ann Emerg Med 1997;
29:518 23.
[19] Sharma S, Riviello JJ, Harper MB, et al. The role of emergent neuroimaging in children with
new-onset afebrile seizures. An Pediatr (Barc) 2003;111:1 6.
[20] Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990;323:
1468 74.
[21] Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970 6.
[22] Haafiz A, Kissoon N. Status epilepticus: current concepts. Pediatr Emerg Care 1999;15:119 29.
[23] Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Pediatr Clin North Am 2001;48:
683 94.
[24] Wolf SM, Ochoa JG, Conway EE. Seizure management in pediatric patients for the nineties.
Pediatr Ann 1998;27:653 64.
[25] Fitzgerald BJ, Okos AJ, Miller JW. Treatment of out of hospital status epilepticus with diaze-
pam rectal gel. Seizure 2003;12:52 5.
[26] Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of
prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999;353:623 6.
[27] Chamberlain JM, Altiere MA, Futterman C, et al. A prospective, randomized study comparing
intramuscular midazolam with intravenous diazepam for the treatment of seizures in children.
Pediatr Emerg Care 1997;13:92 4.
[28] Vilke GM, Sharieff GQ, Marino A, et al. Midazolam for the treatment of out of hospital pedi-
atric seizures. Prehosp Emerg Care 2002;6:215 7.
[29] Wheless J. Treatment of acute seizures and status epilepticus in children. J Child Neurol 1999;
20:S47 51.
[30] Russell RJ, Parks B. Anticonvulsant medications. Pediatr Ann 1999;28:238 45.
[31] Vining EP, Freeman JM. Where, why, and what type of therapy. Pediatr Ann 1985;14:741 5.
[32] Abramowicz M. Drugs for epilepsy. Med Lett Drugs Ther 1995;37:37 40.
[33] Bergin AM. Pharmacotherapy of pediatric epilepsy. Expert Opin Pharmacother 2003;4:421 31.
[34] Shinnar S, Berg AT, Moshe SL, et al. The risk of seizure recurrence after a first unprovoked
afebrile seizure in childhood: an extended follow-up. Pediatr 1996;98:216 25.
[35] Zupance ML. Neonatal seizures. Pediatr Clin North Am 2004;51:961 78.
[36] Stafstrom C. Neonatal seizures. Pediatr Rev 1995;16:248 55.
[37] Bernes S, Kaplan AM. Evolution of neonatal seizures. Pediatr Clin North Am 1994;41:
1069 104.
[38] Rennie JM, Boylan GB. Neonatal seizures and their treatment. Curr Opin Neurol 2003;16:
177 81.
[39] Evans D, Levene M. Neonatal seizures. Arch Dis Child Fetal Neonatal Ed 1998;78:F70 5.
[40] Ng E, Klinger G, Shah V, Taddio A. Safety of benzodiazepines in newborns. Ann Pharmacother
2002;36:1150 5.
[41] Provisional Committee on Quality Improvement, Subcommittee on Febrile Seizures. Prac-
tice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure.
An Pediatr (Barc) 1996;97:769 72.
[42] Committee on Quality Improvement, Subcommittee on Febrile Seizures. Practice parameter:
long-term treatment of the child with simple febrile seizures. An Pediatr (Barc) 1999;103:
1307 9.
[43] Warden CR, Zibulewsky J, Mace S, et al. Evaluation and management of febrile seizures in the
out of hospital and emergency department settings. Ann Emerg Med 2003;41:215 22.
 seizures in children 277

[44] Chiu SS, Tse CYC, Lau YL, et al. Influenza A infection is an important cause of febrile seizures.
Pediatr 2001;108:e63.
[45] Barone SR, Kaplan MH, Krilov LR. Human herpesvirus-6 infection in children with first febrile
seizures. J Pediatr 1995;127:95 7.
[46] Chamberlain JM, Gorman RL. Occult bacteremia inc children with simple febrile seizures.
Am J Dis Child 1988;142:1073 6.
[47] Trainor JL, Hampers LC, Krug SE, et al. Children with first-time simple febrile seizures are
at low risk of serious bacterial illness. Acad Emerg Med 2001;8:781 7.